Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer

about

Glenmark Life Sciences is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.

1061.60 -9.10 (-0.85%)

40.43% Gain from 52W Low

59,520 NSE+BSE Volume

NSE 29 May, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

40.0 / 100

Mid Valuation

31.3 / 100

Technically Neutral

46.4 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 22%

Alivus Life Sciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

Search Inside the pdf :

23 May, 2025 BSE INDIA

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ear…

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ear…

pdf link

16 May, 2025 BSE INDIA

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…

pdf link

23 Jan, 2025 BSE INDIA

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Ana…

pdf link

25 Oct, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

pdf link

25 Oct, 2024 TRENDLYNE

Glenmark Life Sciences Results Earnings Call for Q2FY25

Glenmark Life Sciences Results Earnings Call for Q2FY25

link

02 Aug, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

pdf link

27 Jul, 2024 TRENDLYNE

Glenmark Life Sciences Results Earnings Call for Q1FY25

Glenmark Life Sciences Results Earnings Call for Q1FY25

audio link

26 Jul, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

pdf link

03 May, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

pdf link

26 Apr, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-A…

pdf link

25 Apr, 2024 TRENDLYNE

Glenmark Life Sciences Results Earnings Call for Q4FY24

Glenmark Life Sciences Results Earnings Call for Q4FY24

audio link

31 Jan, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-E…

pdf link

All Earnings Calls

Annual Report Mar-2024

Annual Report Mar-2023

Annual Report Mar-2022

25 May, 2022 INDIA RATINGS

India Ratings Affirms Glenmark Life Sciences at IND AA-/Stable

link

15 May, 2025 BSE INDIA

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…

pdf link

23 Jan, 2025 BSE INDIA

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Inv…

pdf link

24 Oct, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

25 Jul, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

25 Apr, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

11 Mar, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

23 Jan, 2024 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

20 Oct, 2023 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

21 Jul, 2023 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

27 Apr, 2023 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

27 Jan, 2023 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

17 Nov, 2022 BSE INDIA

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-I…

pdf link

Alivus Life Sciences Ltd. FAQ

How is Alivus Life Sciences Ltd. today?

Alivus Life Sciences Ltd. today is trading in the red, and is down by -0.85% at 1061.60.

How has Alivus Life Sciences Ltd. performed historically?

Alivus Life Sciences Ltd. is currently trading down -0.85% on an intraday basis. In the past week the stock fell -3.60%. stock has been up 16.08% in the past quarter and rose 28.48% in the past year. You can view this in the overview section.